K130831

Substantially Equivalent

MALDI BIOTYPER CA (MBT-CA) SYSTEM

Applicant: Bruker Daltonics, Inc.
Product code: PEX
Advisory panel: Microbiology
Date received: 2013-03-26
Decision date: 2013-11-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beverly, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.